Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Syros Pharmaceuticals, Inc. (SYRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.8867-0.0255 (-2.80%)
At close: 04:00PM EDT
0.8980 +0.01 (+1.27%)
After hours: 07:06PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • B
    Blockbuster
    (CING) $1.27 --MC $13 mil ....BIG Phase 3 Asset and imminent data readout coming next week = $$$$$$$$$$
  • g
    george
    we all have a different degree of tolerance as far as stock losses.. also own 70k shares @ 3.67 ps.
  • g
    george
    Jersey, I agree with you however I'm sure in the negotiations with TYME different scenarios where discussed.. Anyway us retail investors Will not have any serious impact on the outcome let's hope for the best.
  • j
    jerzy
    how come I didn't get anything yet ?
  • j
    jerzy
    I don't really care what will happen here in next few months. They have lots of things going on, humongous pipeline for small bio, and to me is worth to wait a year or more. Any FDA good respons will send this to double digits ,so to me is worth to wait ,to many of you isn't then sell it and move on. I own 136k shares and not selling any ,patience always pay off, at least to me.
  • j
    jerzy
    I don't think they are going to do anything before we vote on the merger and same goes to TYME.
  • g
    george
    Jersy, you should check with your broker they received the proxy first.
  • M
    Mike
    Musing. Expecting proxy ballots any day now for TYME & SYROS retail stockholders.Also thinking the election to be simultaneous. The pps for both have been pretty flat. #$%$ Y-on-Y for all retailers. Beneficial holders have all signed off by SEC filings. One big family, waiting on consummation.Thinking the timing on coming events have to be simultaneous to avoid wild PPS swings from day-traders which would skew the pre-agreed terms:Excerpt ?July 5th Announcement (SYROS)~~~~~~~~~~~~~~~~~Upon the closing of the Merger, the Company expects to issue approximately 74.3 million shares of the Company?s common stock to Tyme stockholders, Assuming that Tyme net cash as of the closing of the Merger is approximately $60 million and Tyme stockholders are expected to receive approximately 0.4312 shares of the Company?s common stock for each share?.~~~~~~~~~~~~~~~~~PPS of each July 5th ?17tt?-------------------Tyme .292 ?.296Syrs .87?.93Syros is set to pick up those cash reserves, which are expected to total $60 million after costs, by giving stock to Tyme shareholders. In conjunction with the merger, Syros has put together a private investment round. Syros? founding investor Flagship Pioneering is participating in the $130 million financing with Avidity Partners, Deep Track Capital, Bain Capital Life Sciences, Invus and other backers. Link:https://www.fiercebiotech.com/biotech/buying-tyme-syros-inks-190m-merger-flagship-backed-financing-extend-cash-runway-2025GLTUA
    Syros Pharmaceuticals has bought itself that most prized of assets in today’s biotech market: time. | Syros Pharmaceuticals has bought itself that most prized of assets in today’s biotech market: time. By merging with the floundering Tyme Technologie
    Syros Pharmaceuticals has bought itself that most prized of assets in today’s biotech market: time. | Syros Pharmaceuticals has bought itself that most prized of assets in today’s biotech market: time. By merging with the floundering Tyme Technologie
    www.fiercebiotech.com
    Bullish
  • D
    Daniel
    Why is $SYRS SP dropping right after the $TYME acquisition?
    Bullish
  • K
    Kuryo193
  • M
    Morten
    After private placement, cash from TYME, and 74,3 mill new shares there will be between 1,6 and 1,98 cash per share.
  • j
    jerzy
    SYRS made an excellent deal by merging with TYME . 240 million on hand and enough to go into 2025 . Getting pipe line with multy cancer, and covid potencial drugs ,this is huge. Few read out by end of this year .
    Getting foot into Mayo and Georgetown University is a huge jump. Patience will pay handsomely here.
  • j
    jerzy
    Syros Pharmaceuticals, Inc. (SYRS) Moves to Strong Buy: Rationale Behind the Upgrade
  • M
    Martin
    What's the basis for the Jalper Sadeh investigation into whether this is good value for Syros share holders? Maybe some major shareholder asked them to, i guess?
  • M
    Morten
    Money in the box until 2025, way to go, cool.
  • j
    jerzy
    Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey.
  • j
    jerzy
    This is a great deal. SYRS is adding tremendous pipeline . Fake lawsuit scam. They want to scare small retailers and buy cheap shares. Hold on guys, patience here will reward you.
  • j
    jerzy
    Zacks rating STRONG BUY, only 5% stocks get this rating. Hold on guys this is a diament .
  • M
    Michael
    Congrads to the new bagholders who bought in the $1.40 range after hours, nothing like a 40% shellacking to start the day lololol
Advertisement
Advertisement